EVALUATION OF NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY INVIVO IN PATIENTS TREATED WITH HIGH-DOSE INTERLEUKIN-2 AND ADOPTIVE TRANSFER OF AUTOLOGOUS LAK CELLS

被引：17
|
作者：
WALEWSKI, J
PAIETTA, E
DUTCHER, J
WIERNIK, PH
机构：
[1] MONTEFIORE MED CTR,DEPT ONCOL,111 E 210TH ST,BRONX,NY 10467
[2] ALBERT EINSTEIN MED CTR,DEPT MED,BRONX,NY 10467
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1989年 / 115卷 / 02期
关键词：
D O I：
10.1007/BF00397919
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：170 / 174
页数：5
相关论文
共 50 条
  • [21] Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors
    Sankhla, SK
    Nadkarni, JS
    Bhagwati, SN
    JOURNAL OF NEURO-ONCOLOGY, 1996, 27 (02) : 133 - 140
  • [22] LYSIS OF HUMAN-MALIGNANT MESOTHELIOMA CELLS BY NATURAL-KILLER (NK) AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    MANNING, LS
    BOWMAN, RV
    DARBY, SB
    ROBINSON, BWS
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (06): : 1369 - 1374
  • [23] INFLUENCE OF DIFFERENT CYTOKINES ON THE GENERATION OF INTERLEUKIN-2 INDUCED LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    BERGMANN, L
    WEIDMANN, E
    REUSCH, C
    MITROU, PS
    BLUT, 1988, 57 (04): : 248 - 248
  • [24] EFFICACY OF LYMPHOKINE ACTIVATED KILLER (LAK) CELLS AND OF HIGH-DOSE INTERLEUKIN-2 (IL2) INVIVO IN THE THERAPY OF DISSEMINATED MURINE LEUKEMIA
    THOMPSON, JA
    PEACE, DJ
    GREENBERG, PD
    CHEEVER, MA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 346 - 346
  • [25] HYPOVITAMINOSIS-C IN PATIENTS TREATED WITH HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    MARCUS, SL
    PETRYLAK, DP
    DUTCHER, JP
    PAIETTA, E
    CIOBANU, N
    STRAUMAN, J
    WIERNIK, PH
    HUTNER, SH
    FRANK, O
    BAKER, H
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 54 (06): : S1292 - S1297
  • [26] LYMPHOKINE-ACTIVATED KILLER (LAK) CELL PHENOMENON IN CLUSTER HEADACHE - INVITRO ACTIVATION BY RECOMBINANT INTERLEUKIN-2
    GIACOVAZZO, M
    STIRPARO, G
    DESTEFANO, L
    RINALDI, C
    MARTELLETTI, P
    HEADACHE, 1988, 28 (04): : 292 - 292
  • [27] MONOCLONAL-ANTIBODIES (MABS) THAT MODULATE THE RESPONSE OF NATURAL-KILLER (NK) CELLS AND LYMPHOKINE ACTIVATED KILLER (LAK) CELLS TO RECOMBINANT INTERLEUKIN-2
    VUJANOVIC, NL
    CHAMBERS, WH
    DELEO, AB
    HERBERMAN, RB
    HISERODT, JC
    FASEB JOURNAL, 1988, 2 (06): : A1652 - A1652
  • [28] LYMPHOKINE-ACTIVATED KILLER (LAK) CELL PHENOMENON IN CLUSTER HEADACHE - INVITRO ACTIVATION BY RECOMBINANT INTERLEUKIN-2
    GIACOVAZZO, M
    STIRPARO, G
    DESTEFANO, L
    MARTELLETTI, P
    RINALDIGARACI, C
    HEADACHE, 1989, 29 (03): : 177 - 179
  • [29] LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS - INTERFERON-GAMMA SYNERGIZES WITH INTERLEUKIN-2 TO INDUCE LAK CYTOTOXICITY IN HOMOGENEOUS LEUKEMIC PREPARATIONS
    KAUFMANN, Y
    DAVIDSOHN, J
    LEVANON, M
    ICEKSON, I
    REVEL, M
    RAMOT, B
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 58 (02): : 278 - 288
  • [30] MUCOSAL LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY IN INFLAMMATORY BOWEL-DISEASE (IBD)
    SHINODA, M
    KUSUGAMI, K
    TANIMOTO, M
    HARUTA, J
    KUROIWA, A
    INA, K
    MORISE, K
    MORITA, M
    IOKAWA, H
    ISHIHARA, A
    SARAI, S
    GASTROENTEROLOGY, 1993, 104 (04) : A781 - A781
12345